5408 篇
13915 篇
478257 篇
16334 篇
11777 篇
3948 篇
6564 篇
1254 篇
75723 篇
38123 篇
12190 篇
1672 篇
2873 篇
3423 篇
642 篇
1242 篇
1980 篇
4927 篇
3893 篇
5511 篇
全球视网膜药物市场报告(2025-2029年)
Global Retinal Drugs Market 2025-2029
Retinal drugs are the medications that are used in the treatment of retinal diseases. Anti-vascular endothelial growth factor (VEGF) agents and corticosteroids are the two major drug classes that are being used for the treatment of various retinal diseases such as wet age-related Macular degeneration (AMD), macular edema following retinal vein occlusion (RVO), diabetic macular edema (DME), diabetic retinopathy, and myopic choroidal neovascularization (mCNV). Among them, anti-VEGF agents are considered the gold standard for the treatment of various retinal diseases such as AMD, DME, and RVO.